Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_45349 | 19 | 0.39 | Mlig455_068174 | Neo: - Age: - |
Mlig455_068174 {REF} {Length: 495} {NoTransDecoderORF} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | -4.637 | 0.629 | 1.00000 | 1.00000 | |
RegionR2 | 2.893 | 0.629 | 0.27753 | 0.66353 | |
RegionR3 | -0.724 | 0.629 | 1.00000 | 1.00000 | |
RegionR4 | 1.458 | 0.629 | 0.14857 | 0.39736 | |
RegionR5 | -0.919 | 0.629 | 0.99996 | 1.00000 | |
RegionR6 | 1.616 | 0.629 | 0.16682 | 0.72220 | |
RegionR7 | 2.527 | 0.629 | 0.37606 | 1.00000 | |
RegionR8 | -2.214 | 0.629 | 1.00000 | 1.00000 |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | 0.658 | 0.629 | 1.00000 | 1.00000 | |
RegenerationR2 | 0.61 | 0.629 | 0.88941 | 1.00000 | |
RegenerationR3 | 2.336 | 0.629 | 0.31295 | 0.74321 | |
RegenerationR4 | -1.99 | 0.629 | 0.34174 | 0.77288 | |
RegenerationR5 | 0.503 | 0.629 | 1.00000 | 1.00000 | |
RegenerationR6 | -1.514 | 0.629 | 0.23644 | 0.58385 | |
RegenerationBL | -1.386 | 0.629 | 1.00000 | 1.00000 | |
RegenerationTP | -0.86 | 0.629 | 1.00000 | 1.00000 |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_45349 | 19 | 0.39 | Mlig455_068174 | Neo: - Age: - |
1 | - | - | - | - | - | 1.000 | Mlig455_068174 {REF} {Length: 495} {NoTransDecoderORF} | |
2. | MligTC455_36194 | 30 | 0.61 | Mlig455_064360, Mlig455_064382 | Neo: - Age: - |
B3GNT4 | 0.999 | - | - | - | - | - | 0.999 | Mlig455_064360 {REF} {Length: 3119} {Pfam: Galactosyltransferase [PF01762.23, score=116.7]} {Human: ENSG00000176383, B3GNT4, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4, [Score=101, Expect=5e-23]} {Mouse: ENSMUSG00000031803, B3gnt3, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3, [Score=94.7, Expect=9e-21]; ENSMUSG00000051650, B3gnt2, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2, [Score=94.0, Expect=2e-20]; ENSMUSG00000067370, B3galt4, UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4, [Score=93.6, Expect=3e-20]; ENSMUSG00000029431, B3gnt4, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4, [Score=93.2, Expect=2e-20]; ENSMUSG00000022686, B3gnt5, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5, [Score=91.7, Expect=1e-19]} {Dmel: FBgn0031988, CG8668, [Score=90.1, Expect=8e-19]} {Celegans: WBGene00007104, B0024.15, Hexosyltransferase, [RH, Score=90.9, Expect=8e-20]} {Smed: dd_Smed_v6_9789_0_1, dd_Smed_v6_9789_0_1, [Score=165, Expect=5e-47]} {RNA1310_43172} {RNA815_26726} Mlig455_064382 {REF} {Length: 3084} {Pfam: Galactosyltransferase [PF01762.23, score=116.7]} {Human: ENSG00000176383, B3GNT4, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4, [Score=101, Expect=5e-23]} {Mouse: ENSMUSG00000031803, B3gnt3, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3, [Score=94.7, Expect=9e-21]; ENSMUSG00000051650, B3gnt2, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2, [Score=94.4, Expect=2e-20]; ENSMUSG00000029431, B3gnt4, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4, [Score=93.6, Expect=2e-20]; ENSMUSG00000067370, B3galt4, UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4, [Score=93.6, Expect=2e-20]; ENSMUSG00000022686, B3gnt5, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5, [Score=92.0, Expect=9e-20]} {Dmel: FBgn0031988, CG8668, [Score=90.1, Expect=8e-19]} {Celegans: WBGene00007104, B0024.15, Hexosyltransferase, [RH, Score=90.9, Expect=8e-20]} {Smed: dd_Smed_v6_9789_0_1, dd_Smed_v6_9789_0_1, [Score=165, Expect=5e-47]} {RNA1310_43172} {RNA815_26726} |
3. | MligTC455_43324 | 71 | 1.47 | Mlig455_041984 | Neo: - Age: - Region-enriched R2: 6.623/0.00573 |
0.999 | - | - | - | - | - | 0.999 | Mlig455_041984 {REF} {Length: 388} {NoTransDecoderORF} {RNA1509_49821} {RNA1310_52560.2} {RNA815_59873} | |
4. | MligTC455_45031 | 6 | 0.12 | Mlig455_018753 | Neo: - Age: - |
0.998 | - | - | - | - | - | 0.998 | Mlig455_018753 {REF} {Length: 1240} {RNA1509_46869} {RNA1310_21302} {RNA815_22307} | |
5. | MligTC455_24270 | 71 | 1.47 | Mlig455_005120 | Neo: - Age: - |
CHRNA7 | 0.997 | - | - | - | - | - | 0.997 | Mlig455_005120 {REF} {Length: 1530} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=115.0]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=66.6]} {Human: ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=148, Expect=4e-39]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=147, Expect=5e-39]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=145, Expect=4e-38]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=146, Expect=2e-38]; ENSMUSG00000032269, Htr3a, 5-hydroxytryptamine (serotonin) receptor 3A, [Score=140, Expect=1e-36]} {Dmel: FBgn0028875, nAChRalpha5, nicotinic Acetylcholine Receptor alpha5, [Score=135, Expect=5e-34]} {Celegans: WBGene00000060, acr-21, AcetylCholine Receptor, [Score=134, Expect=9e-35]} {Smed: dd_Smed_v6_8058_0_1, dd_Smed_v6_8058_0_1, [Score=133, Expect=4e-34]} {RNA1509_43533} {RNA1310_20839.2} {RNA815_22406} |
6. | MligTC455_50927 | 254 | 5.29 | Mlig455_070541, Mlig455_070562 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.296 Region-enriched R2: 7.883/0.00008 |
FZD4 | 0.997 | - | - | - | - | - | 0.997 | Mlig455_070541 {REF} {Length: 3522} {Pfam: Frizzled/Smoothened family membrane region [PF01534.19, score=339.1]; Fz domain [PF01392.24, score=88.1]} {Human: ENSG00000174804, FZD4, frizzled class receptor 4, [RH, Score=446, Expect=1e-149]} {Mouse: ENSMUSG00000049791, Fzd4, frizzled class receptor 4, [RH, Score=446, Expect=1e-149]} {Dmel: FBgn0001085, fz, frizzled, [Score=315, Expect=3e-98]} {Celegans: WBGene00000478, cfz-2, Frizzled-2, [Score=284, Expect=5e-87]} {Smed: dd_Smed_v6_7210_0_1, dd_Smed_v6_7210_0_1, [RH, Score=471, Expect=6e-159]} {RNA1509_15834} {RNA1310_3800, RNA1509_15834} {RNA1509_15834, RNA815_19571} Mlig455_070562 {REF} {Length: 3527} {Pfam: Frizzled/Smoothened family membrane region [PF01534.19, score=339.1]; Fz domain [PF01392.24, score=88.1]} {Human: ENSG00000174804, FZD4, frizzled class receptor 4, [RH, Score=446, Expect=1e-149]} {Mouse: ENSMUSG00000049791, Fzd4, frizzled class receptor 4, [RH, Score=446, Expect=2e-149]} {Dmel: FBgn0001085, fz, frizzled, [Score=315, Expect=3e-98]} {Celegans: WBGene00000478, cfz-2, Frizzled-2, [Score=284, Expect=5e-87]} {Smed: dd_Smed_v6_7210_0_1, dd_Smed_v6_7210_0_1, [RH, Score=470, Expect=8e-159]} {RNA1509_15834} {RNA1310_3800} {RNA815_19571} |
7. | MligTC455_09224 | 21 | 0.43 | Mlig455_038078 | Neo: - Age: - |
0.996 | - | - | - | - | - | 0.996 | Mlig455_038078 {REF} {Length: 771} {Pfam: PAN domain [PF00024.28, score=28.0]} {RNA1509_46267} {RNA1310_51656} {RNA815_32275.1} | |
8. | MligTC455_17804 | 27 | 0.56 | Mlig455_069447 | Neo: - Age: - |
0.996 | - | - | - | - | - | 0.996 | Mlig455_069447 {REF} {Length: 955} {RNA1310_40722} {RNA815_46396} | |
9. | MligTC455_53546 | 130 | 2.72 | Mlig455_013326, Mlig455_013334 | Neo: - Age: - Region-enriched R2: 6.753/0.01892 |
MMP9 | 0.996 | - | - | - | - | - | 0.996 | Mlig455_013326 {REF} {Length: 1449} {Pfam: Fibronectin type II domain [PF00040.21, score=92.5]} {Human: ENSG00000100985, MMP9, matrix metallopeptidase 9, [RH, Score=87.8, Expect=3e-18]} {Mouse: ENSMUSG00000017737, Mmp9, matrix metallopeptidase 9, [RH, Score=82.4, Expect=1e-16]; ENSMUSG00000031740, Mmp2, matrix metallopeptidase 2, [RH, Score=78.6, Expect=2e-15]} {Smed: dd_Smed_v6_14558_0_1, dd_Smed_v6_14558_0_1, [RH, Score=138, Expect=3e-38]} {RNA1310_38631} {RNA815_51136} Mlig455_013334 {REF} {Length: 1398} {Pfam: Fibronectin type II domain [PF00040.21, score=92.1]} {Human: ENSG00000100985, MMP9, matrix metallopeptidase 9, [RH, Score=89.4, Expect=1e-18]} {Mouse: ENSMUSG00000017737, Mmp9, matrix metallopeptidase 9, [RH, Score=84.0, Expect=4e-17]} {Smed: dd_Smed_v6_12601_0_1, dd_Smed_v6_12601_0_1, [RH, Score=140, Expect=2e-38]} {RNA1310_38631} {RNA815_51136} |
10. | MligTC455_47393 | 241 | 5.03 | Mlig455_008718, Mlig455_063579 | Neo: - Age: Down-Up-Down Region-enriched R2: 3.683/0.00849 |
CALM2 | 0.995 | - | - | - | - | - | 0.995 | Mlig455_008718 {REF} {Length: 1727} {Pfam: EF hand [PF00036.34, score=99.3]; EF-hand domain pair [PF13499.8, score=95.1]; EF-hand domain [PF13405.8, score=86.1]; EF-hand domain pair [PF13833.8, score=76.8]; EF hand [PF13202.8, score=75.3]; EF-hand domain [PF14658.8, score=46.0]; Secreted protein acidic and rich in cysteine Ca binding region [PF10591.11, score=38.5]; Cytoskeletal-regulatory complex EF hand [PF12763.9, score=27.9]; EF-hand domain [PF08976.13, score=23.4]; Uncharacterised protein family (UPF0154) [PF03672.15, score=18.7]} {Human: ENSG00000143933, CALM2, calmodulin 2, [Score=108, Expect=4e-30]; ENSG00000160014, CALM3, calmodulin 3, [Score=108, Expect=4e-30]; ENSG00000198668, CALM1, calmodulin 1, [Score=108, Expect=4e-30]} {Mouse: ENSMUSG00000019370, Calm3, calmodulin 3, [Score=108, Expect=2e-30]; ENSMUSG00000036438, Calm2, calmodulin 2, [Score=108, Expect=2e-30]; ENSMUSG00000001175, Calm1, calmodulin 1, [Score=108, Expect=2e-30]; ENSMUSG00000063130, Calml3, calmodulin-like 3, [Score=106, Expect=1e-29]} {Dmel: FBgn0000253, Cam, Calmodulin, [Score=107, Expect=3e-30]} {Celegans: WBGene00000552, cmd-1, Calmodulin, [Score=107, Expect=2e-30]} {Smed: dd_Smed_v6_3441_0_1, dd_Smed_v6_3441_0_1, [Score=114, Expect=8e-33]} {RNA1310_33847.1} {RNA815_17211} Mlig455_063579 {REF} {Length: 2562} {Pfam: EF hand [PF00036.34, score=95.8]; EF-hand domain pair [PF13499.8, score=92.8]; EF-hand domain [PF13405.8, score=82.9]; EF-hand domain pair [PF13833.8, score=74.4]; EF hand [PF13202.8, score=72.2]; EF-hand domain [PF14658.8, score=43.8]; Secreted protein acidic and rich in cysteine Ca binding region [PF10591.11, score=38.5]; Cytoskeletal-regulatory complex EF hand [PF12763.9, score=25.6]; EF-hand domain [PF08976.13, score=21.4]} {Human: ENSG00000143933, CALM2, calmodulin 2, [Score=111, Expect=7e-30]; ENSG00000198668, CALM1, calmodulin 1, [Score=108, Expect=3e-29]; ENSG00000160014, CALM3, calmodulin 3, [Score=108, Expect=3e-29]} {Mouse: ENSMUSG00000001175, Calm1, calmodulin 1, [Score=111, Expect=7e-30]; ENSMUSG00000036438, Calm2, calmodulin 2, [Score=108, Expect=2e-29]; ENSMUSG00000019370, Calm3, calmodulin 3, [Score=108, Expect=2e-29]; ENSMUSG00000063130, Calml3, calmodulin-like 3, [Score=106, Expect=9e-29]} {Dmel: FBgn0000253, Cam, Calmodulin, [Score=107, Expect=3e-29]} {Celegans: WBGene00000552, cmd-1, Calmodulin, [Score=107, Expect=2e-29]} {Smed: dd_Smed_v6_3441_0_1, dd_Smed_v6_3441_0_1, [Score=111, Expect=9e-31]} {RNA1310_12431.1} {RNA815_17211} |
11. | MligTC455_51807 | 28 | 0.59 | Mlig455_046394 | Neo: - Age: - |
GPSM2 | 0.995 | - | - | - | - | - | 0.995 | Mlig455_046394 {REF} {Length: 3388} {Pfam: Tetratricopeptide repeat [PF13424.8, score=114.4]; Tetratricopeptide repeat [PF13176.8, score=96.0]; Tetratricopeptide repeat [PF00515.30, score=94.3]; GoLoco motif [PF02188.19, score=85.6]; Tetratricopeptide repeat [PF07719.19, score=55.0]; Tetratricopeptide repeat [PF13181.8, score=42.2]; Tetratricopeptide repeat [PF13374.8, score=32.8]; Rapsyn N-terminal myristoylation and linker region [PF10579.11, score=20.1]} {Human: ENSG00000121957, GPSM2, G protein signaling modulator 2, [RH, Score=542, Expect=0.0]} {Mouse: ENSMUSG00000027883, Gpsm2, G-protein signalling modulator 2 (AGS3-like, C. elegans), [RH, Score=532, Expect=1e-180]; ENSMUSG00000026930, Gpsm1, G-protein signalling modulator 1 (AGS3-like, C. elegans), [RH, Score=511, Expect=1e-172]} {Dmel: FBgn0040080, pins, partner of inscuteable, [RH, Score=530, Expect=2e-180]} {Celegans: WBGene00000092, ags-3, Activator of G protein Signalling, [RH, Score=266, Expect=7e-80]} {Smed: dd_Smed_v6_6548_1_1, dd_Smed_v6_6548_1_1, [RH, Score=477, Expect=1e-159]} {RNA1310_18538} {RNA815_41322} |
12. | MligTC455_15327 | 51 | 1.07 | Mlig455_003799, Mlig455_054316 | Neo: - Age: Down-Up-Down |
CPLX1 | 0.994 | - | - | - | - | - | 0.994 | Mlig455_003799 {REF} {Length: 3120} {Pfam: Synaphin protein [PF05835.14, score=100.6]; PVL ORF-50-like family [PF07768.13, score=19.1]} {Human: ENSG00000168993, CPLX1, complexin 1, [RH, Score=55.8, Expect=9e-10]; ENSG00000145920, CPLX2, complexin 2, [RH, Score=54.3, Expect=1e-09]} {Mouse: ENSMUSG00000033615, Cplx1, complexin 1, [Score=57.0, Expect=2e-10]} {Dmel: FBgn0041605, cpx, complexin, [Score=66.2, Expect=9e-14]} {Celegans: WBGene00022271, cpx-1, Putative complexin-1, [Score=77.8, Expect=2e-18]} {Smed: dd_Smed_v6_9918_0_1, dd_Smed_v6_9918_0_1, [Score=91.7, Expect=6e-24]} {RNA1310_47061} Mlig455_054316 {REF} {Length: 3045} {Pfam: Synaphin protein [PF05835.14, score=100.6]; PVL ORF-50-like family [PF07768.13, score=19.1]} {Human: ENSG00000168993, CPLX1, complexin 1, [RH, Score=55.8, Expect=9e-10]; ENSG00000145920, CPLX2, complexin 2, [RH, Score=54.3, Expect=1e-09]} {Mouse: ENSMUSG00000033615, Cplx1, complexin 1, [Score=57.0, Expect=2e-10]} {Dmel: FBgn0041605, cpx, complexin, [Score=66.2, Expect=9e-14]} {Celegans: WBGene00022271, cpx-1, Putative complexin-1, [Score=77.8, Expect=2e-18]} {Smed: dd_Smed_v6_9918_0_1, dd_Smed_v6_9918_0_1, [Score=91.7, Expect=6e-24]} {RNA1310_47061} |
13. | MligTC455_21502 | 36 | 0.75 | Mlig455_018529 | Neo: - Age: - Region-enriched R2: 5.380/0.01311 |
0.994 | - | - | - | - | - | 0.994 | Mlig455_018529 {REF} {Length: 1004} {Pfam: Fas apoptotic inhibitory molecule (FAIM1) [PF06905.15, score=43.7]} {Mouse: ENSMUSG00000032463, Faim, Fas apoptotic inhibitory molecule, [Score=54.7, Expect=2e-09]} {Smed: dd_Smed_v6_4798_0_1, dd_Smed_v6_4798_0_1, [RH, Score=75.1, Expect=7e-18]} {RNA1310_42034} {RNA815_19884} | |
14. | MligTC455_19079 | 218 | 4.54 | Mlig455_008746, Mlig455_008760 | Neo: - Age: Down-Up-Up Region-specific R2: 6.705 Region-enriched R2: 6.864/0.00152 |
0.993 | - | - | - | - | - | 0.993 | Mlig455_008746 {REF} {Length: 652} {RNA1310_75395.1} {RNA815_42524} Mlig455_008760 {REF} {Length: 1051} {RNA1310_75395.1} {RNA815_42524} |
|
15. | MligTC455_32028 | 19 | 0.39 | Mlig455_019343, Mlig455_019346 | Neo: - Age: - |
GRIA2 | 0.993 | - | - | - | - | - | 0.993 | Mlig455_019343 {REF} {Length: 3241} {Pfam: Ligand-gated ion channel [PF00060.28, score=96.6]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=57.9]; Receptor family ligand binding region [PF01094.30, score=49.1]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=19.0]} {Human: ENSG00000120251, GRIA2, glutamate ionotropic receptor AMPA type subunit 2, [Score=150, Expect=1e-36]; ENSG00000164418, GRIK2, glutamate ionotropic receptor kainate type subunit 2, [Score=149, Expect=2e-36]; ENSG00000155511, GRIA1, glutamate ionotropic receptor AMPA type subunit 1, [Score=146, Expect=2e-35]; ENSG00000152578, GRIA4, glutamate ionotropic receptor AMPA type subunit 4, [Score=144, Expect=9e-35]; ENSG00000171189, GRIK1, glutamate ionotropic receptor kainate type subunit 1, [Score=144, Expect=1e-34]} {Mouse: ENSMUSG00000056073, Grik2, glutamate receptor, ionotropic, kainate 2 (beta 2), [Score=150, Expect=5e-37]; ENSMUSG00000033981, Gria2, glutamate receptor, ionotropic, AMPA2 (alpha 2), [Score=150, Expect=8e-37]; ENSMUSG00000020524, Gria1, glutamate receptor, ionotropic, AMPA1 (alpha 1), [Score=145, Expect=3e-35]; ENSMUSG00000025892, Gria4, glutamate receptor, ionotropic, AMPA4 (alpha 4), [Score=145, Expect=3e-35]; ENSMUSG00000022935, Grik1, glutamate receptor, ionotropic, kainate 1, [Score=144, Expect=5e-35]} {Dmel: FBgn0039927, CG11155, [Score=158, Expect=1e-39]} {Celegans: WBGene00001614, glr-3, GLutamate Receptor family (AMPA), [Score=125, Expect=3e-29]} {Smed: dd_Smed_v6_31078_0_1, dd_Smed_v6_31078_0_1, [Score=250, Expect=2e-75]} {RNA1509_10728} {RNA1310_4026} {RNA815_8415.1} Mlig455_019346 {REF} {Length: 519} {Pfam: Receptor family ligand binding region [PF01094.30, score=21.5]} {RNA1509_10728} {RNA1310_4026} {RNA815_8415.2} |
16. | MligTC455_36959 | 14 | 0.28 | Mlig455_019348, Mlig455_019567, Mlig455_045238 | Neo: - Age: - |
AC243734.1 | 0.993 | - | - | - | - | - | 0.993 | Mlig455_019348 {REF} {Length: 1134} Mlig455_019567 {REF} {Length: 1135} Mlig455_045238 {REF} {Length: 1757} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=170.5]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=109.4]} {Human: ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=244, Expect=1e-73]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=244, Expect=1e-73]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=243, Expect=5e-73]; ENSG00000174343, CHRNA9, cholinergic receptor nicotinic alpha 9 subunit, [Score=233, Expect=3e-69]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=244, Expect=1e-73]; ENSMUSG00000029205, Chrna9, cholinergic receptor, nicotinic, alpha polypeptide 9, [Score=235, Expect=2e-70]} {Dmel: FBgn0000039, nAChRalpha2, nicotinic Acetylcholine Receptor alpha2, [Score=252, Expect=5e-76]} {Celegans: WBGene00000058, acr-19, AcetylCholine Receptor; Acetylcholine receptor (63.2 kD) (Acr-19), [Score=234, Expect=1e-69]} {Smed: dd_Smed_v6_23922_0_1, dd_Smed_v6_23922_0_1, [Score=242, Expect=2e-72]} {RNA1310_104931} {RNA815_34654} |
17. | MligTC455_45769 | 79 | 1.65 | Mlig455_018116 | Neo: - Age: - |
0.993 | - | - | - | - | - | 0.993 | Mlig455_018116 {REF} {Length: 3312} {Pfam: NACHT domain [PF05729.14, score=33.6]; AAA ATPase domain [PF13191.8, score=25.1]; AAA domain [PF13401.8, score=19.4]} {Smed: dd_Smed_v6_9074_0_1, dd_Smed_v6_9074_0_1, [Score=138, Expect=2e-33]} {RNA1509_44893} {RNA1310_38241} {RNA815_33748} | |
18. | MligTC455_53414 | 331 | 6.9 | Mlig455_053442 | Neo: - Age: - Region-specific R2: 4.308 Region-enriched R2: 3.374/0.00040 |
RP1 | 0.993 | - | - | - | - | - | 0.993 | Mlig455_053442 {REF} {Length: 1156} {Pfam: PLAT/LH2 domain [PF01477.25, score=155.8]; Doublecortin [PF03607.19, score=103.5]; Embryo-specific protein 3, (ATS3) [PF06232.13, score=22.0]} {Human: ENSG00000104237, RP1, RP1, axonemal microtubule associated, [Score=473, Expect=5e-146]} {Mouse: ENSMUSG00000025900, Rp1, retinitis pigmentosa 1 (human), [Score=454, Expect=1e-136]} {Dmel: FBgn0261387, CG17528, [Score=56.6, Expect=1e-07]} {Celegans: WBGene00006993, zyg-8, Serine/threonine-protein kinase zyg-8, [Score=75.5, Expect=2e-13]} {Smed: dd_Smed_v6_10315_0_2, dd_Smed_v6_10315_0_2, [Score=698, Expect=0.0]} {RNA1509_21828} {RNA1310_33070.1} {RNA815_13802.1} |
19. | MligTC455_19876 | 135 | 2.82 | Mlig455_024520, Mlig455_024523 | Neo: - Age: - |
0.992 | - | - | - | - | - | 0.992 | Mlig455_024520 {REF} {Length: 2352} {Pfam: CD20-like family [PF04103.17, score=40.9]} {Mouse: ENSMUSG00000048004, Tmem196, transmembrane protein 196, [Score=63.5, Expect=2e-12]} {Smed: dd_Smed_v6_14043_0_1, dd_Smed_v6_14043_0_1, [Score=184, Expect=5e-59]} {RNA1509_25506} {RNA1310_9338} {RNA815_23744} Mlig455_024523 {REF} {Length: 2311} {Smed: dd_Smed_v6_14043_0_1, dd_Smed_v6_14043_0_1, [Score=153, Expect=3e-47]} {RNA1509_25506} {RNA1310_9338} {RNA815_23744} |
|
20. | MligTC455_43534 | 34 | 0.71 | Mlig455_030976 | Neo: - Age: - |
0.992 | - | - | - | - | - | 0.992 | Mlig455_030976 {REF} {Length: 1067} {RNA1310_40722} {RNA815_46396} | |
21. | MligTC455_53415 | 319 | 6.64 | Mlig455_053444 | Neo: - Age: Up-Down-Down Region-specific R2: 4.862 Region-enriched R2: 4.179/0.00011 |
RP1 | 0.992 | - | - | - | - | - | 0.992 | Mlig455_053444 {REF} {Length: 4944} {Pfam: PLAT/LH2 domain [PF01477.25, score=155.3]; Doublecortin [PF03607.19, score=100.5]; Embryo-specific protein 3, (ATS3) [PF06232.13, score=22.5]; Fibroblast growth factor [PF00167.20, score=18.6]} {Human: ENSG00000104237, RP1, RP1, axonemal microtubule associated, [Score=471, Expect=6e-145]} {Mouse: ENSMUSG00000025900, Rp1, retinitis pigmentosa 1 (human), [Score=453, Expect=3e-136]} {Dmel: FBgn0261387, CG17528, [Score=56.6, Expect=1e-07]} {Celegans: WBGene00006993, zyg-8, Serine/threonine-protein kinase zyg-8, [Score=75.9, Expect=1e-13]} {Smed: dd_Smed_v6_10315_0_2, dd_Smed_v6_10315_0_2, [Score=691, Expect=0.0]} {RNA1509_59703} {RNA1310_2710} {RNA815_17469} |
22. | MligTC455_13975 | 63 | 1.31 | Mlig455_070810 | Neo: - Age: - Region-enriched R2: 7.513/0.00519 |
0.991 | - | - | - | - | - | 0.991 | Mlig455_070810 {REF} {Length: 1542} {Pfam: Otopetrin [PF03189.15, score=108.9]} {Dmel: FBgn0031514, CG3332, [Score=74.3, Expect=3e-14]} {Celegans: WBGene00015035, otpl-1, OToPetrin-Like, [Score=47.8, Expect=9e-06]} {Smed: dd_Smed_v6_13612_0_3, dd_Smed_v6_13612_0_3, [Score=119, Expect=2e-29]} {RNA1310_93602} {RNA815_48323} | |
23. | MligTC455_02985 | 22 | 0.45 | Mlig455_057981 | Neo: - Age: - |
0.99 | - | - | - | - | - | 0.990 | Mlig455_057981 {REF} {Length: 299} {RNA1509_13251} {RNA1310_4626} | |
24. | MligTC455_26601 | 40 | 0.84 | Mlig455_000748 | Neo: - |
0.99 | - | - | - | - | - | 0.990 | Mlig455_000748 {REF} {Length: 4122} {Smed: dd_Smed_v6_17076_0_2, dd_Smed_v6_17076_0_2, [Score=84.3, Expect=1e-17]} {RNA1310_16747.1} {RNA815_12493} | |
25. | MligTC455_29408 | 45 | 0.94 | Mlig455_038322 | Neo: - Age: - Region-enriched R2: 8.586/0.00762 |
MB | 0.99 | - | - | - | - | - | 0.990 | Mlig455_038322 {REF} {Length: 2059} {Pfam: Globin [PF00042.24, score=57.8]} {Human: ENSG00000198125, MB, myoglobin, [RH, Score=47.8, Expect=5e-07]} {Mouse: ENSMUSG00000018893, Mb, myoglobin, [RH, Score=45.4, Expect=2e-06]} {Celegans: WBGene00008996, glb-14, GLoBin related, [Score=51.6, Expect=4e-08]} {Smed: dd_Smed_v6_15997_0_1, dd_Smed_v6_15997_0_1, [RH, Score=63.5, Expect=1e-12]} {RNA1509_48898} {RNA1310_47695} {RNA815_7096.1} |
26. | MligTC455_43322 | 67 | 1.4 | Mlig455_032888 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.946 Region-enriched R2: 7.587/0.00001 |
0.99 | - | - | - | - | - | 0.990 | Mlig455_032888 {REF} {Length: 2179} {RNA1509_40507, RNA1509_49821} {RNA1310_22780, RNA1509_40507} {RNA1509_40507, RNA815_9762} | |
27. | MligTC455_50454 | 394 | 8.21 | Mlig455_057487 | Neo: - Age: Down-Up-Up Region-enriched R2: 5.517/0.00000 |
0.99 | - | - | - | - | - | 0.990 | Mlig455_057487 {REF} {Length: 724} {Pfam: Insulin/IGF/Relaxin family [PF00049.20, score=33.5]; Nematode insulin-related peptide beta type [PF03488.16, score=20.4]} {RNA1509_58074} {RNA1310_51990} {RNA815_25071} | |
28. | MligTC455_18506 | 59 | 1.23 | Mlig455_038054 | Neo: - Age: Down-Up-Down |
SP9 | 0.989 | - | - | - | - | - | 0.989 | Mlig455_038054 {REF} {Length: 3168} {Pfam: Zinc-finger double domain [PF13465.8, score=49.0]; Zinc finger, C2H2 type [PF00096.28, score=40.9]; C2H2-type zinc finger [PF13894.8, score=26.8]} {Human: ENSG00000217236, SP9, Sp9 transcription factor, [RH, Score=202, Expect=4e-59]; ENSG00000164651, SP8, Sp8 transcription factor, [RH, Score=202, Expect=5e-59]} {Mouse: ENSMUSG00000068859, Sp9, trans-acting transcription factor 9, [RH, Score=202, Expect=3e-59]; ENSMUSG00000048562, Sp8, trans-acting transcription factor 8, [RH, Score=201, Expect=9e-59]} {Dmel: FBgn0020378, Sp1, [RH, Score=198, Expect=6e-56]} {Celegans: WBGene00012735, sptf-3, SP (Specificity Protein) Transcription Factor, [Score=137, Expect=1e-35]} {Smed: dd_Smed_v6_17385_0_1, dd_Smed_v6_17385_0_1, [RH, Score=160, Expect=5e-46]} {RNA1310_42373} |
29. | MligTC455_44578 | 12 | 0.24 | Mlig455_048995 | Neo: Int S/G2/M Age: - Region-enriched R2: 5.730/0.04221 |
0.989 | - | - | - | - | - | 0.989 | Mlig455_048995 {REF} {Length: 2090} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=110.0]} {RNA1310_22174} {RNA815_24783} | |
30. | MligTC455_09653 | 51 | 1.06 | Mlig455_044944 | Neo: - Age: - |
SLC17A6 | 0.988 | - | - | - | - | - | 0.988 | Mlig455_044944 {REF} {Length: 2769} {Pfam: Major Facilitator Superfamily [PF07690.18, score=118.9]} {Human: ENSG00000091664, SLC17A6, solute carrier family 17 member 6, [Score=260, Expect=4e-79]; ENSG00000104888, SLC17A7, solute carrier family 17 member 7, [Score=248, Expect=1e-74]} {Mouse: ENSMUSG00000030500, Slc17a6, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6, [Score=259, Expect=8e-79]; ENSMUSG00000070570, Slc17a7, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 7, [Score=249, Expect=3e-75]; ENSMUSG00000019935, Slc17a8, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 8, [Score=248, Expect=2e-74]} {Dmel: FBgn0031424, VGlut, Vesicular glutamate transporter, [Score=223, Expect=1e-64]} {Celegans: WBGene00001135, eat-4, Probable vesicular glutamate transporter eat-4, [Score=203, Expect=2e-58]} {Smed: dd_Smed_v6_21295_0_1, dd_Smed_v6_21295_0_1, [RH, Score=616, Expect=0.0]} {RNA1310_79790} {RNA815_45443} |
31. | MligTC455_19276 | 1694 | 35.28 | Mlig455_057303 | Neo: - Age: Down-Down-Up Region-specific R2: 5.711 Region-enriched R2: 6.117/0.00000 |
0.988 | - | - | - | - | - | 0.988 | Mlig455_057303 {REF} {Length: 1196} {Pfam: TATA-binding related factor (TRF) of subunit 20 of Mediator complex [PF08612.13, score=80.6]} {Smed: dd_Smed_v6_9879_0_1, dd_Smed_v6_9879_0_1, [RH, Score=73.9, Expect=1e-15]} {RNA1509_58478} {RNA1310_35292} {RNA815_20171} | |
32. | MligTC455_19278 | 4335 | 90.31 | Mlig455_057304, Mlig455_070944 | Neo: - Age: logFC(26M/2M)=0.686 Region-specific R2: 5.590 Region-enriched R2: 5.465/0.00000 |
CHRNA10 | 0.988 | - | - | - | - | - | 0.988 | Mlig455_057304 {REF} {Length: 1001} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=71.6]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=77.0, Expect=2e-16]} {Mouse: ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=75.9, Expect=4e-16]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=75.5, Expect=6e-16]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=73.9, Expect=2e-15]} {Dmel: FBgn0086778, nAChRalpha7, nicotinic Acetylcholine Receptor alpha7, [Score=93.6, Expect=2e-22]} {Celegans: WBGene00000058, acr-19, AcetylCholine Receptor; Acetylcholine receptor (63.2 kD) (Acr-19), [Score=100, Expect=5e-25]} {Smed: dd_Smed_v6_11955_0_1, dd_Smed_v6_11955_0_1, [Score=82.8, Expect=8e-19]} {RNA1509_23115} {RNA1310_34970} {RNA815_15305.1} Mlig455_070944 {REF} {Length: 1060} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=88.2]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=95.9, Expect=6e-22]} {Mouse: ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=96.3, Expect=3e-22]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=94.7, Expect=1e-21]} {Dmel: FBgn0086778, nAChRalpha7, nicotinic Acetylcholine Receptor alpha7, [Score=112, Expect=7e-28]} {Celegans: WBGene00000058, acr-19, AcetylCholine Receptor; Acetylcholine receptor (63.2 kD) (Acr-19), [Score=118, Expect=4e-30]} {Smed: dd_Smed_v6_18184_0_1, dd_Smed_v6_18184_0_1, [Score=98.6, Expect=2e-23]} {RNA1509_23115, RNA1509_43907, RNA1509_9432} {RNA1310_34970, RNA1509_23115, RNA1509_43907, RNA1509_9432} {RNA1509_23115, RNA1509_43907, RNA1509_9432, RNA815_15305.1} |
33. | MligTC455_41055 | 112 | 2.34 | Mlig455_044574 | Neo: - Age: Up-Down-Down Region-specific R2: 4.659 Region-enriched R2: 6.247/0.00008 |
0.988 | - | - | - | - | - | 0.988 | Mlig455_044574 {REF} {Length: 1203} {Smed: dd_Smed_v6_9736_0_1, dd_Smed_v6_9736_0_1, [Score=86.7, Expect=1e-20]} {RNA1509_58567} {RNA1310_87689} {RNA815_53353} | |
34. | MligTC455_50348 | 34 | 0.7 | Mlig455_012803 | Neo: - Age: - |
0.988 | - | - | - | - | - | 0.988 | Mlig455_012803 {REF} {Length: 488} {RNA1509_48155} {RNA1310_70969.2} {RNA815_39712} | |
35. | MligTC455_14107 | 77 | 1.61 | Mlig455_025350, Mlig455_025394 | Neo: - Age: - Region-enriched R2: 10.212/0.00000 |
0.987 | - | - | - | - | - | 0.987 | Mlig455_025350 {REF} {Length: 568} {RNA1310_64375} {RNA815_39588} Mlig455_025394 {REF} {Length: 749} {RNA1509_58356} {RNA1310_64375} {RNA815_39588} |
|
36. | MligTC455_14856 | 14 | 0.29 | Mlig455_023184 | Neo: - Age: - |
ANGPTL7 | 0.987 | - | - | - | - | - | 0.987 | Mlig455_023184 {REF} {Length: 1290} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=129.4]; PAN domain [PF00024.28, score=23.8]} {Human: ENSG00000171819, ANGPTL7, angiopoietin like 7, [Score=105, Expect=1e-25]; ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=103, Expect=3e-24]} {Mouse: ENSMUSG00000028989, Angptl7, angiopoietin-like 7, [Score=104, Expect=1e-25]; ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=102, Expect=4e-24]} {Dmel: FBgn0033312, CG8642, [Score=96.7, Expect=2e-22]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=98.6, Expect=5e-23]} {RNA1509_58115} {RNA1310_36699.1} {RNA815_17918.1} |
37. | MligTC455_15253 | 11 | 0.22 | Mlig455_010266 | Neo: - Age: - |
0.987 | - | - | - | - | - | 0.987 | Mlig455_010266 {REF} {Length: 252} {NoTransDecoderORF} {RNA815_48483} | |
38. | MligTC455_25072 | 4443 | 92.56 | Mlig455_015899 | Neo: - Age: Down-Down-Down, logFC(26M/2M)=-1.175 Region-enriched R2: 4.389/0.00000 |
PI16 | 0.987 | - | - | - | - | - | 0.987 | Mlig455_015899 {REF} {Length: 2017} {Pfam: Cysteine-rich secretory protein family [PF00188.28, score=71.8]} {Human: ENSG00000164530, PI16, peptidase inhibitor 16, [Score=112, Expect=1e-26]} {Mouse: ENSMUSG00000024011, Pi16, peptidase inhibitor 16, [RH, Score=115, Expect=5e-28]} {Dmel: FBgn0038126, CG8483, [Score=95.5, Expect=2e-21]} {Celegans: WBGene00011462, vap-2, Venom-Allergen-like Protein, [RH, Score=85.5, Expect=5e-18]} {Smed: dd_Smed_v6_2512_0_1, dd_Smed_v6_2512_0_1, [Score=140, Expect=2e-39]} {RNA1509_5027} {RNA1310_1356.1} {RNA815_4508} |
39. | MligTC455_29915 | 50 | 1.04 | Mlig455_027934 | Neo: - Age: Down-Up-Up Region-enriched R2: 6.881/0.04464 |
ANGPTL1 | 0.987 | - | - | - | - | - | 0.987 | Mlig455_027934 {REF} {Length: 2265} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=43.0]} {Human: ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=48.9, Expect=9e-06]} {Dmel: FBgn0031804, CG9500, [Score=53.1, Expect=9e-08]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=49.7, Expect=1e-06]} {RNA1509_53291} {RNA1310_38229.1} {RNA815_10579.1} |
40. | MligTC455_31273 | 40 | 0.83 | Mlig455_017570 | Neo: - Age: - |
JMJD6 | 0.987 | - | - | - | - | - | 0.987 | Mlig455_017570 {REF} {Length: 2550} {Pfam: Cupin-like domain [PF13621.8, score=84.8]; JmjC domain, hydroxylase [PF02373.24, score=41.9]; Cupin superfamily protein [PF08007.14, score=22.1]} {Human: ENSG00000070495, JMJD6, jumonji domain containing 6, arginine demethylase and lysine hydroxylase, [Score=81.6, Expect=3e-16]} {Mouse: ENSMUSG00000056962, Jmjd6, jumonji domain containing 6, [Score=79.0, Expect=2e-15]} {Dmel: FBgn0038948, PSR, phosphatidylserine receptor, [Score=77.8, Expect=3e-15]} {Celegans: WBGene00004205, psr-1, Bifunctional arginine demethylase and lysyl-hydroxylase psr-1, [Score=88.6, Expect=6e-19]} {Smed: dd_Smed_v6_12267_0_1, dd_Smed_v6_12267_0_1, [RH, Score=327, Expect=7e-108]} {RNA1310_17984} {RNA815_15470} |
41. | MligTC455_32366 | 22 | 0.45 | Mlig455_034995, Mlig455_056739 | Neo: - Age: - |
KREMEN2 | 0.987 | - | - | - | - | - | 0.987 | Mlig455_034995 {REF} {Length: 838} {Pfam: WSC domain [PF01822.21, score=57.3]; PAN domain [PF00024.28, score=30.2]} {Human: ENSG00000131650, KREMEN2, kringle containing transmembrane protein 2, [Score=48.9, Expect=2e-06]} {Mouse: ENSMUSG00000040680, Kremen2, kringle containing transmembrane protein 2, [Score=53.1, Expect=7e-08]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=64.7, Expect=6e-12]} {RNA1310_90615} {RNA815_32019} Mlig455_056739 {REF} {Length: 3691} {RNA1310_90615} {RNA815_24291.1} |
42. | MligTC455_38487 | 21 | 0.43 | Mlig455_035154 | Neo: - Age: - |
0.987 | - | - | - | - | - | 0.987 | Mlig455_035154 {REF} {Length: 903} {Pfam: WSC domain [PF01822.21, score=52.5]; PAN domain [PF00024.28, score=30.4]} {Mouse: ENSMUSG00000040680, Kremen2, kringle containing transmembrane protein 2, [Score=47.4, Expect=5e-06]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=50.8, Expect=4e-07]} {RNA1310_44717} {RNA815_43195} | |
43. | MligTC455_42513 | 70 | 1.45 | Mlig455_023063, Mlig455_023065 | Neo: - Age: - |
KCNC2 | 0.987 | - | - | - | - | - | 0.987 | Mlig455_023063 {REF} {Length: 2276} {Pfam: Ion transport protein [PF00520.33, score=123.8]; BTB/POZ domain [PF02214.24, score=86.7]; Ion channel [PF07885.18, score=37.0]} {Human: ENSG00000166006, KCNC2, potassium voltage-gated channel subfamily C member 2, [Score=284, Expect=7e-87]; ENSG00000129159, KCNC1, potassium voltage-gated channel subfamily C member 1, [Score=280, Expect=4e-85]; ENSG00000116396, KCNC4, potassium voltage-gated channel subfamily C member 4, [Score=271, Expect=2e-81]} {Mouse: ENSMUSG00000058975, Kcnc1, potassium voltage gated channel, Shaw-related subfamily, member 1, [Score=279, Expect=4e-85]; ENSMUSG00000035681, Kcnc2, potassium voltage gated channel, Shaw-related subfamily, member 2, [Score=271, Expect=3e-81]} {Dmel: FBgn0003386, Shaw, Shaker cognate w, [Score=285, Expect=3e-87]} {Celegans: WBGene00008819, shw-1, SHaW family of potassium channels, [Score=303, Expect=4e-94]} {Smed: dd_Smed_v6_13250_0_2, dd_Smed_v6_13250_0_2, [Score=286, Expect=3e-88]} {RNA1509_33421} {RNA1310_15684} {RNA815_16308} Mlig455_023065 {REF} {Length: 2276} {Pfam: Ion transport protein [PF00520.33, score=123.8]; BTB/POZ domain [PF02214.24, score=86.7]; Ion channel [PF07885.18, score=37.0]} {Human: ENSG00000166006, KCNC2, potassium voltage-gated channel subfamily C member 2, [Score=284, Expect=7e-87]; ENSG00000129159, KCNC1, potassium voltage-gated channel subfamily C member 1, [Score=280, Expect=4e-85]; ENSG00000116396, KCNC4, potassium voltage-gated channel subfamily C member 4, [Score=271, Expect=2e-81]} {Mouse: ENSMUSG00000058975, Kcnc1, potassium voltage gated channel, Shaw-related subfamily, member 1, [Score=279, Expect=4e-85]; ENSMUSG00000035681, Kcnc2, potassium voltage gated channel, Shaw-related subfamily, member 2, [Score=271, Expect=3e-81]} {Dmel: FBgn0003386, Shaw, Shaker cognate w, [Score=285, Expect=3e-87]} {Celegans: WBGene00008819, shw-1, SHaW family of potassium channels, [Score=303, Expect=4e-94]} {Smed: dd_Smed_v6_13250_0_2, dd_Smed_v6_13250_0_2, [Score=286, Expect=3e-88]} {RNA1509_33421} {RNA1310_15684} {RNA815_16308} |
44. | MligTC455_50146 | 37 | 0.77 | Mlig455_050983 | Neo: - Age: - |
NPSR1 | 0.987 | - | - | - | - | - | 0.987 | Mlig455_050983 {REF} {Length: 1326} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=105.5]} {Human: ENSG00000187258, NPSR1, neuropeptide S receptor 1, [Score=63.5, Expect=1e-10]} {Mouse: ENSMUSG00000029255, Gnrhr, gonadotropin releasing hormone receptor, [Score=66.6, Expect=4e-12]; ENSMUSG00000044014, Npy5r, neuropeptide Y receptor Y5, [Score=65.5, Expect=3e-11]} {Dmel: FBgn0036278, CrzR, Corazonin receptor, [Score=72.8, Expect=1e-13]} {Celegans: WBGene00013642, daf-38, G-protein coupled receptor daf-38, [Score=65.5, Expect=1e-11]} {Smed: dd_Smed_v6_75337_0_1, dd_Smed_v6_75337_0_1, [Score=66.6, Expect=2e-12]} {RNA1310_64751.2} |
45. | MligTC455_54282 | 74 | 1.54 | Mlig455_020191 | Neo: - Age: - |
0.987 | - | - | - | - | - | 0.987 | Mlig455_020191 {REF} {Length: 937} {RNA1509_48973} {RNA1310_40738.2} {RNA815_31898} | |
46. | MligTC455_03382 | 210 | 4.37 | Mlig455_057035 | Neo: - Age: - Region-enriched R2: 3.628/0.00113 |
PDE1C | 0.986 | - | - | - | - | - | 0.986 | Mlig455_057035 {REF} {Length: 2458} {Pfam: 3'5'-cyclic nucleotide phosphodiesterase [PF00233.21, score=275.1]; 3'5'-cyclic nucleotide phosphodiesterase N-terminal [PF08499.14, score=94.2]} {Human: ENSG00000154678, PDE1C, phosphodiesterase 1C, [RH, Score=546, Expect=0.0]} {Mouse: ENSMUSG00000004347, Pde1c, phosphodiesterase 1C, [RH, Score=546, Expect=0.0]} {Dmel: FBgn0264815, Pde1c, Phosphodiesterase 1c, [RH, Score=538, Expect=0.0]} {Celegans: WBGene00011433, pde-1, Probable 3',5'-cyclic phosphodiesterase pde-1, [RH, Score=482, Expect=2e-164]} {Smed: dd_Smed_v6_11039_0_2, dd_Smed_v6_11039_0_2, [RH, Score=613, Expect=0.0]} {RNA1509_46084} {RNA1310_8143.1} {RNA815_6002} |
47. | MligTC455_22686 | 26 | 0.55 | Mlig455_000566, Mlig455_030366 | Neo: - Age: - |
GRIK3 | 0.986 | - | - | - | - | - | 0.986 | Mlig455_000566 {REF} {Length: 2943} {Pfam: Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=78.1]; Ligand-gated ion channel [PF00060.28, score=52.0]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=48.7]} {Human: ENSG00000163873, GRIK3, glutamate ionotropic receptor kainate type subunit 3, [Score=157, Expect=5e-39]; ENSG00000171189, GRIK1, glutamate ionotropic receptor kainate type subunit 1, [Score=154, Expect=6e-38]; ENSG00000164418, GRIK2, glutamate ionotropic receptor kainate type subunit 2, [Score=154, Expect=7e-38]} {Mouse: ENSMUSG00000056073, Grik2, glutamate receptor, ionotropic, kainate 2 (beta 2), [Score=152, Expect=2e-37]; ENSMUSG00000001985, Grik3, glutamate receptor, ionotropic, kainate 3, [Score=151, Expect=4e-37]; ENSMUSG00000022935, Grik1, glutamate receptor, ionotropic, kainate 1, [Score=150, Expect=4e-37]; ENSMUSG00000003378, Grik5, glutamate receptor, ionotropic, kainate 5 (gamma 2), [Score=145, Expect=2e-35]} {Dmel: FBgn0039916, Ekar, Eye-enriched kainate receptor, [Score=147, Expect=4e-36]} {Celegans: WBGene00001614, glr-3, GLutamate Receptor family (AMPA), [Score=137, Expect=4e-33]} {Smed: dd_Smed_v6_22973_0_1, dd_Smed_v6_22973_0_1, [Score=155, Expect=5e-39]} {RNA1310_20394.1} {RNA815_45848} Mlig455_030366 {REF} {Length: 2933} {Pfam: Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=78.1]; Ligand-gated ion channel [PF00060.28, score=51.5]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=48.7]} {Human: ENSG00000163873, GRIK3, glutamate ionotropic receptor kainate type subunit 3, [Score=157, Expect=4e-39]; ENSG00000171189, GRIK1, glutamate ionotropic receptor kainate type subunit 1, [Score=154, Expect=5e-38]; ENSG00000164418, GRIK2, glutamate ionotropic receptor kainate type subunit 2, [Score=152, Expect=2e-37]} {Mouse: ENSMUSG00000001985, Grik3, glutamate receptor, ionotropic, kainate 3, [Score=151, Expect=4e-37]; ENSMUSG00000056073, Grik2, glutamate receptor, ionotropic, kainate 2 (beta 2), [Score=150, Expect=5e-37]; ENSMUSG00000022935, Grik1, glutamate receptor, ionotropic, kainate 1, [Score=150, Expect=4e-37]; ENSMUSG00000003378, Grik5, glutamate receptor, ionotropic, kainate 5 (gamma 2), [Score=145, Expect=3e-35]; ENSMUSG00000032017, Grik4, glutamate receptor, ionotropic, kainate 4, [Score=144, Expect=9e-35]} {Dmel: FBgn0039916, Ekar, Eye-enriched kainate receptor, [Score=147, Expect=5e-36]} {Celegans: WBGene00001614, glr-3, GLutamate Receptor family (AMPA), [Score=137, Expect=5e-33]} {Smed: dd_Smed_v6_22973_0_1, dd_Smed_v6_22973_0_1, [Score=154, Expect=1e-38]} {RNA1310_20394.1} {RNA815_45848} |
48. | MligTC455_31626 | 38 | 0.79 | Mlig455_032857 | Neo: - Age: - |
SLC23A1 | 0.986 | - | - | - | - | - | 0.986 | Mlig455_032857 {REF} {Length: 2462} {Pfam: Permease family [PF00860.22, score=281.6]} {Human: ENSG00000170482, SLC23A1, solute carrier family 23 member 1, [Score=400, Expect=4e-132]; ENSG00000089057, SLC23A2, solute carrier family 23 member 2, [Score=380, Expect=1e-123]} {Mouse: ENSMUSG00000029847, Slc23a4, solute carrier family 23 member 4, [Score=421, Expect=4e-140]} {Dmel: FBgn0037807, CG6293, [Score=355, Expect=2e-115]} {Celegans: WBGene00008252, C51E3.6, [RH, Score=250, Expect=1e-75]} {Smed: dd_Smed_v6_9401_0_1, dd_Smed_v6_9401_0_1, [RH, Score=304, Expect=9e-96]} {RNA1509_16219} {RNA1310_39982} {RNA815_42063} |
49. | MligTC455_40328 | 26 | 0.54 | Mlig455_054438 | Neo: - Age: - |
0.986 | - | - | - | - | - | 0.986 | Mlig455_054438 {REF} {Length: 1987} {NoTransDecoderORF} {RNA1509_27938} {RNA1310_55383} | |
50. | MligTC455_40989 | 801 | 16.68 | Mlig455_016294 | Neo: - Age: logFC(26M/2M)=0.270 |
PKD2 | 0.986 | - | - | - | - | - | 0.986 | Mlig455_016294 {REF} {Length: 3179} {Pfam: Polycystin cation channel [PF08016.14, score=486.5]; Ion transport protein [PF00520.33, score=90.3]; EF hand [PF00036.34, score=23.7]} {Human: ENSG00000118762, PKD2, polycystin 2, transient receptor potential cation channel, [RH, Score=718, Expect=0.0]; ENSG00000107593, PKD2L1, polycystin 2 like 1, transient receptor potential cation channel, [RH, Score=712, Expect=0.0]} {Mouse: ENSMUSG00000037578, Pkd2l1, polycystic kidney disease 2-like 1, [RH, Score=704, Expect=0.0]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [RH, Score=310, Expect=2e-91]} {Celegans: WBGene00004035, pkd-2, Polycystin-2, [RH, Score=370, Expect=7e-116]} {Smed: dd_Smed_v6_13327_0_1, dd_Smed_v6_13327_0_1, [RH, Score=743, Expect=0.0]} {RNA1509_14023, RNA1509_24240} {RNA1310_4836.1, RNA1509_14023, RNA1509_24240} {RNA1509_14023, RNA1509_24240, RNA815_4677} |
51. | MligTC455_45021 | 381 | 7.95 | Mlig455_046686 | Neo: - Age: Down-Up-Up Region-enriched R2: 3.428/0.03156 |
AVP | 0.986 | - | - | - | - | - | 0.986 | Mlig455_046686 {REF} {Length: 1388} {Pfam: Neurohypophysial hormones, C-terminal Domain [PF00184.19, score=36.2]} {Human: ENSG00000101200, AVP, arginine vasopressin, [Score=54.3, Expect=2e-09]} {Mouse: ENSMUSG00000037727, Avp, arginine vasopressin, [Score=53.1, Expect=3e-09]} {RNA1509_50574} {RNA1310_38922} {RNA815_23813} |
52. | MligTC455_49688 | 126 | 2.63 | Mlig455_014720 | Neo: - Age: - |
0.986 | - | - | - | - | - | 0.986 | Mlig455_014720 {REF} {Length: 1470} {RNA1310_68781} {RNA815_18548} | |
53. | MligTC455_54204 | 344 | 7.17 | Mlig455_006398 | Neo: - Age: Up-Down-Down, logFC(26M/2M)=0.351 Region-specific R2: 5.395 Region-enriched R2: 4.187/0.01201 |
MYH6 | 0.986 | - | - | - | - | - | 0.986 | Mlig455_006398 {REF} {Length: 7465} {Pfam: Myosin head (motor domain) [PF00063.23, score=927.6]; Myosin tail [PF01576.21, score=593.3]; Myosin N-terminal SH3-like domain [PF02736.21, score=60.7]; Crescentin protein [PF19220.2, score=26.4]; Macoilin family [PF09726.11, score=19.0]} {Human: ENSG00000197616, MYH6, myosin heavy chain 6, [RH, Score=2074, Expect=0.0]; ENSG00000092054, MYH7, myosin heavy chain 7, [RH, Score=2064, Expect=0.0]; ENSG00000125414, MYH2, myosin heavy chain 2, [RH, Score=2019, Expect=0.0]; ENSG00000109061, MYH1, myosin heavy chain 1, [RH, Score=2012, Expect=0.0]; ENSG00000133020, MYH8, myosin heavy chain 8, [RH, Score=2006, Expect=0.0]; ENSG00000264424, MYH4, myosin heavy chain 4, [RH, Score=1991, Expect=0.0]; ENSG00000109063, MYH3, myosin heavy chain 3, [RH, Score=1973, Expect=0.0]} {Mouse: ENSMUSG00000040752, Myh6, myosin, heavy polypeptide 6, cardiac muscle, alpha, [RH, Score=2073, Expect=0.0]; ENSMUSG00000053093, Myh7, myosin, heavy polypeptide 7, cardiac muscle, beta, [RH, Score=2063, Expect=0.0]; ENSMUSG00000057003, Myh4, myosin, heavy polypeptide 4, skeletal muscle, [RH, Score=2039, Expect=0.0]; ENSMUSG00000056328, Myh1, myosin, heavy polypeptide 1, skeletal muscle, adult, [RH, Score=2016, Expect=0.0]; ENSMUSG00000055775, Myh8, myosin, heavy polypeptide 8, skeletal muscle, perinatal, [RH, Score=2014, Expect=0.0]; ENSMUSG00000033196, Myh2, myosin, heavy polypeptide 2, skeletal muscle, adult, [RH, Score=2008, Expect=0.0]; ENSMUSG00000020908, Myh3, myosin, heavy polypeptide 3, skeletal muscle, embryonic, [RH, Score=1981, Expect=0.0]; ENSMUSG00000060180, Myh13, myosin, heavy polypeptide 13, skeletal muscle, [RH, Score=1978, Expect=0.0]} {Dmel: FBgn0264695, Mhc, Myosin heavy chain, [RH, Score=2100, Expect=0.0]} {Celegans: WBGene00019064, myo-5, MYOsin heavy chain structural genes, [RH, Score=1993, Expect=0.0]} {Smed: dd_Smed_v6_579_0_1, dd_Smed_v6_579_0_1, [RH, Score=2702, Expect=0.0]} {RNA1509_16048, RNA1509_42411} {RNA1310_1388, RNA1509_42411} {RNA1509_42411, RNA815_129.1} |
54. | MligTC455_00245 | 15 | 0.32 | Mlig455_040042 | Neo: - Age: - |
GPR17 | 0.985 | - | - | - | - | - | 0.985 | Mlig455_040042 {REF} {Length: 1332} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=36.0]} {Human: ENSG00000144230, GPR17, G protein-coupled receptor 17, [Score=48.9, Expect=6e-06]} {Smed: dd_Smed_v6_61185_0_1, dd_Smed_v6_61185_0_1, [Score=70.9, Expect=1e-14]} {RNA1310_142905} |
55. | MligTC455_01197 | 6 | 0.12 | Mlig455_047852 | Neo: - Age: - |
0.985 | - | - | - | - | - | 0.985 | Mlig455_047852 {REF} {Length: 829} {RNA1509_18414} {RNA1310_42507} {RNA815_19425} | |
56. | MligTC455_13375 | 48 | 1 | Mlig455_008269 | Neo: - Age: - Region-enriched R2: 6.043/0.00338 |
0.985 | - | - | - | - | - | 0.985 | Mlig455_008269 {REF} {Length: 2598} {RNA1310_27894} {RNA815_60961} | |
57. | MligTC455_13934 | 17 | 0.36 | Mlig455_006218 | Neo: - Age: - |
WSCD2 | 0.985 | - | - | - | - | - | 0.985 | Mlig455_006218 {REF} {Length: 823} {Pfam: WSC domain [PF01822.21, score=53.1]; PAN domain [PF00024.28, score=24.4]} {Human: ENSG00000075035, WSCD2, WSC domain containing 2, [Score=54.3, Expect=3e-08]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=54.7, Expect=2e-08]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=57.8, Expect=1e-09]} {RNA1509_46267} {RNA1310_43993} {RNA815_32275.1} |
58. | MligTC455_15329 | 22 | 0.47 | Mlig455_060498 | Neo: - Age: - |
0.985 | - | - | - | - | - | 0.985 | Mlig455_060498 {REF} {Length: 1186} {Pfam: PAN domain [PF00024.28, score=18.9]} {Smed: dd_Smed_v6_32483_0_1, dd_Smed_v6_32483_0_1, [Score=63.9, Expect=4e-12]} {RNA1310_37660} {RNA815_17816.1} | |
59. | MligTC455_18139 | 70 | 1.45 | Mlig455_010809 | Neo: - Age: logFC(26M/2M)=-0.809 Region-enriched R2: 6.868/0.00081 |
TRPC5 | 0.985 | - | - | - | - | - | 0.985 | Mlig455_010809 {REF} {Length: 4442} {Pfam: Ion transport protein [PF00520.33, score=98.6]; Transient receptor ion channel II [PF08344.13, score=94.3]; Polycystin cation channel [PF08016.14, score=49.0]; Ankyrin repeats (many copies) [PF13637.8, score=37.1]; Ankyrin repeats (3 copies) [PF12796.9, score=33.2]; Ankyrin repeat [PF13606.8, score=25.4]; Ankyrin repeats (many copies) [PF13857.8, score=24.1]; Ankyrin repeat [PF00023.32, score=23.2]} {Human: ENSG00000072315, TRPC5, transient receptor potential cation channel subfamily C member 5, [RH, Score=743, Expect=0.0]; ENSG00000133107, TRPC4, transient receptor potential cation channel subfamily C member 4, [RH, Score=740, Expect=0.0]} {Mouse: ENSMUSG00000041710, Trpc5, transient receptor potential cation channel, subfamily C, member 5, [RH, Score=744, Expect=0.0]; ENSMUSG00000027748, Trpc4, transient receptor potential cation channel, subfamily C, member 4, [RH, Score=740, Expect=0.0]} {Dmel: FBgn0032593, Trpgamma, Transient receptor potential cation channel gamma, [RH, Score=848, Expect=0.0]} {Celegans: WBGene00006615, trp-2, TRP (Transient receptor potential) channel family; TRP homlogous cation channel protein, [RH, Score=694, Expect=0.0]} {Smed: dd_Smed_v6_20495_0_1, dd_Smed_v6_20495_0_1, [RH, Score=1017, Expect=0.0]} {RNA1509_34138} {RNA1310_12839, RNA1509_34138} {RNA1509_34138, RNA815_17637} |
60. | MligTC455_19248 | 238 | 4.95 | Mlig455_036051 | Neo: - Age: - Region-enriched R2: 8.870/0.00000 |
0.985 | - | - | - | - | - | 0.985 | Mlig455_036051 {REF} {Length: 807} {RNA1509_57448} {RNA1310_51394} {RNA815_26076} | |
61. | MligTC455_22688 | 18 | 0.37 | Mlig455_030413 | Neo: - Age: - |
GRIK3 | 0.985 | - | - | - | - | - | 0.985 | Mlig455_030413 {REF} {Length: 3851} {Pfam: Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=76.0]; Ligand-gated ion channel [PF00060.28, score=51.9]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=45.7]} {Human: ENSG00000163873, GRIK3, glutamate ionotropic receptor kainate type subunit 3, [Score=158, Expect=1e-40]; ENSG00000171189, GRIK1, glutamate ionotropic receptor kainate type subunit 1, [Score=153, Expect=7e-39]} {Mouse: ENSMUSG00000001985, Grik3, glutamate receptor, ionotropic, kainate 3, [Score=149, Expect=7e-38]; ENSMUSG00000022935, Grik1, glutamate receptor, ionotropic, kainate 1, [Score=149, Expect=6e-38]; ENSMUSG00000056073, Grik2, glutamate receptor, ionotropic, kainate 2 (beta 2), [Score=148, Expect=2e-37]} {Dmel: FBgn0039916, Ekar, Eye-enriched kainate receptor, [Score=142, Expect=1e-35]} {Celegans: WBGene00001614, glr-3, GLutamate Receptor family (AMPA), [Score=132, Expect=1e-32]} {Smed: dd_Smed_v6_4267_0_3, dd_Smed_v6_4267_0_3, [Score=149, Expect=5e-38]} {RNA1310_20394.1} {RNA815_45848} |
62. | MligTC455_29587 | 14 | 0.29 | Mlig455_044070 | Neo: - Age: - |
0.985 | - | - | - | - | - | 0.985 | Mlig455_044070 {REF} {Length: 1365} {RNA1509_26262} {RNA1310_30838} {RNA815_35621} | |
63. | MligTC455_40714 | 93 | 1.94 | Mlig455_008848 | Neo: - Age: - Region-enriched R2: 5.100/0.02617 |
0.985 | - | - | - | - | - | 0.985 | Mlig455_008848 {REF} {Length: 2258} {RNA1310_21537} {RNA815_13165} | |
64. | MligTC455_43315 | 118 | 2.46 | Mlig455_022312, Mlig455_069884 | Neo: - Age: logFC(26M/2M)=0.730 |
KREMEN2 | 0.985 | - | - | - | - | - | 0.985 | Mlig455_022312 {REF} {Length: 2816} {Pfam: WSC domain [PF01822.21, score=54.1]} {Human: ENSG00000131650, KREMEN2, kringle containing transmembrane protein 2, [Score=52.0, Expect=2e-07]} {Mouse: ENSMUSG00000040680, Kremen2, kringle containing transmembrane protein 2, [Score=50.1, Expect=5e-07]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=63.9, Expect=1e-11]} {Celegans: WBGene00005024, sqv-6, Xylosyltransferase sqv-6, [Score=47.4, Expect=3e-06]} {RNA1509_40165} {RNA1310_40900} {RNA815_15848} Mlig455_069884 {REF} {Length: 2143} {Pfam: WSC domain [PF01822.21, score=54.1]} {Human: ENSG00000131650, KREMEN2, kringle containing transmembrane protein 2, [Score=52.0, Expect=2e-07]} {Mouse: ENSMUSG00000040680, Kremen2, kringle containing transmembrane protein 2, [Score=50.1, Expect=5e-07]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=63.9, Expect=1e-11]} {Celegans: WBGene00005024, sqv-6, Xylosyltransferase sqv-6, [Score=47.4, Expect=3e-06]} {RNA1509_40165} {RNA1310_40900} {RNA815_15848} |
65. | MligTC455_44195 | 267 | 5.56 | Mlig455_057666 | Neo: - Age: logFC(26M/2M)=0.586 Region-enriched R2: 4.885/0.00002 |
0.985 | - | - | - | - | - | 0.985 | Mlig455_057666 {REF} {Length: 1757} {RNA1509_45654, RNA1509_50922} {RNA1310_26801.2, RNA1509_45654, RNA1509_50922} {RNA1509_45654, RNA1509_50922, RNA815_13136} | |
66. | MligTC455_44810 | 226 | 4.72 | Mlig455_013293, Mlig455_035940, Mlig455_058406, Mlig455_058409 | Neo: - Age: - Region-specific R2: 6.204 Region-enriched R2: 5.509/0.00501 |
0.985 | - | - | - | - | - | 0.985 | Mlig455_013293 {REF} {Length: 1362} {Smed: dd_Smed_v6_42798_0_1, dd_Smed_v6_42798_0_1, [Score=56.6, Expect=2e-09]} {RNA1310_28961.1} {RNA815_27532} Mlig455_035940 {REF} {Length: 1652} {Smed: dd_Smed_v6_42798_0_1, dd_Smed_v6_42798_0_1, [Score=55.8, Expect=3e-09]} {RNA1310_28961.1} {RNA815_27532} Mlig455_058406 {REF} {Length: 991} {Smed: dd_Smed_v6_42798_0_1, dd_Smed_v6_42798_0_1, [Score=55.8, Expect=4e-09]} {RNA1310_28961.1} {RNA815_27532} Mlig455_058409 {REF} {Length: 1311} {Smed: dd_Smed_v6_42798_0_1, dd_Smed_v6_42798_0_1, [Score=55.8, Expect=3e-09]} {RNA1310_28961.1} {RNA815_27532} |
|
67. | MligTC455_45666 | 652 | 13.58 | Mlig455_013011, Mlig455_013040 | Neo: - Age: Up-Down-Up Region-specific R2: 4.509 Region-enriched R2: 3.140/0.01108 |
0.985 | - | - | - | - | - | 0.985 | Mlig455_013011 {REF} {Length: 1193} {RNA1509_13068} {RNA1310_46610} {RNA815_23273} Mlig455_013040 {REF} {Length: 923} {RNA1509_13068} {RNA1310_46610, RNA1509_13068} {RNA1509_13068, RNA815_23273} |
|
68. | MligTC455_50589 | 29 | 0.61 | Mlig455_010626, Mlig455_010716 | Neo: - Age: Down-Up-Down |
0.985 | - | - | - | - | - | 0.985 | Mlig455_010626 {REF} {Length: 2021} {Pfam: Tctex-1 family [PF03645.15, score=27.5]} {RNA1310_36440} Mlig455_010716 {REF} {Length: 2038} {Pfam: Tctex-1 family [PF03645.15, score=27.2]} {RNA1310_36440} |
|
69. | MligTC455_04786 | 26 | 0.55 | Mlig455_043817, Mlig455_047431 | Neo: - Age: - |
0.984 | - | - | - | - | - | 0.984 | Mlig455_043817 {REF} {Length: 319} {NoTransDecoderORF} {RNA1310_64690} Mlig455_047431 {REF} {Length: 2194} {Pfam: Glycine rich protein [PF12810.9, score=25.3]} {RNA1509_16377} {RNA1310_33363.2} {RNA815_25152} |
|
70. | MligTC455_13905 | 34 | 0.71 | Mlig455_023395 | Neo: - Age: - |
0.984 | - | - | - | - | - | 0.984 | Mlig455_023395 {REF} {Length: 1110} {Smed: dd_Smed_v6_12856_0_1, dd_Smed_v6_12856_0_1, [Score=47.0, Expect=2e-06]} {RNA1509_18233} {RNA1310_51675} {RNA815_25040} | |
71. | MligTC455_17299 | 538 | 11.21 | Mlig455_036559, Mlig455_057787 | Neo: - Age: - Region-enriched R2: 5.046/0.00000 |
0.984 | - | - | - | - | - | 0.984 | Mlig455_036559 {REF} {Length: 718} {RNA1509_57277} {RNA1310_52579, RNA1509_57277} {RNA1509_57277, RNA815_26706} Mlig455_057787 {REF} {Length: 741} {RNA1509_57277} {RNA1310_52579} {RNA815_26706} |
|
72. | MligTC455_27938 | 137 | 2.85 | Mlig455_033961 | Neo: - Age: - |
0.984 | - | - | - | - | - | 0.984 | Mlig455_033961 {REF} {Length: 3296} {Pfam: Glycine rich protein [PF12810.9, score=20.4]} {RNA1310_28736.1} {RNA815_45605} | |
73. | MligTC455_41399 | 147 | 3.07 | Mlig455_028472, Mlig455_028497 | Neo: - Age: - Region-enriched R4: 3.401/0.01137 |
FADS2 | 0.984 | - | - | - | - | - | 0.984 | Mlig455_028472 {REF} {Length: 2155} {Pfam: Fatty acid desaturase [PF00487.26, score=111.7]} {Human: ENSG00000134824, FADS2, fatty acid desaturase 2, [Score=348, Expect=8e-118]; ENSG00000149485, FADS1, fatty acid desaturase 1, [Score=339, Expect=4e-115]} {Mouse: ENSMUSG00000024665, Fads2, fatty acid desaturase 2, [Score=357, Expect=4e-121]} {Celegans: WBGene00001395, fat-3, Delta(6)-fatty-acid desaturase fat-3, [Score=107, Expect=1e-26]} {Smed: dd_Smed_v6_10869_0_1, dd_Smed_v6_10869_0_1, [Score=418, Expect=1e-145]} {RNA1509_26943} {RNA1310_8517.1} {RNA815_15928} Mlig455_028497 {REF} {Length: 2199} {TRANSSPLICED} {Pfam: Fatty acid desaturase [PF00487.26, score=113.5]; Cytochrome b5-like Heme/Steroid binding domain [PF00173.30, score=60.8]} {Human: ENSG00000134824, FADS2, fatty acid desaturase 2, [Score=409, Expect=5e-140]; ENSG00000149485, FADS1, fatty acid desaturase 1, [Score=402, Expect=3e-136]} {Mouse: ENSMUSG00000024665, Fads2, fatty acid desaturase 2, [Score=422, Expect=4e-145]} {Dmel: FBgn0264294, Cyt-b5, Cytochrome b5, [Score=47.0, Expect=3e-06]} {Celegans: WBGene00001395, fat-3, Delta(6)-fatty-acid desaturase fat-3, [Score=121, Expect=4e-30]} {Smed: dd_Smed_v6_10869_0_1, dd_Smed_v6_10869_0_1, [RH, Score=476, Expect=3e-167]} {RNA1509_26943} {RNA1310_8517.1} {RNA815_15928} |
74. | MligTC455_42427 | 30 | 0.63 | Mlig455_040552, Mlig455_062085 | Neo: - Age: - |
ANGPT1, ANGPTL2 | 0.984 | - | - | - | - | - | 0.984 | Mlig455_040552 {REF} {Length: 1447} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=132.5]} {Human: ENSG00000154188, ANGPT1, angiopoietin 1, [Score=108, Expect=3e-26]; ENSG00000136859, ANGPTL2, angiopoietin like 2, [Score=108, Expect=3e-26]; ENSG00000171819, ANGPTL7, angiopoietin like 7, [Score=108, Expect=4e-27]; ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=104, Expect=8e-25]} {Mouse: ENSMUSG00000028989, Angptl7, angiopoietin-like 7, [Score=110, Expect=4e-28]; ENSMUSG00000004105, Angptl2, angiopoietin-like 2, [Score=108, Expect=2e-26]; ENSMUSG00000022309, Angpt1, angiopoietin 1, [Score=108, Expect=3e-26]; ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=105, Expect=3e-25]} {Dmel: FBgn0030163, CG1791, [Score=94.4, Expect=3e-23]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=90.1, Expect=3e-20]} {RNA1310_118725} Mlig455_062085 {REF} {Length: 1538} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=130.9]} {Human: ENSG00000136859, ANGPTL2, angiopoietin like 2, [Score=108, Expect=4e-26]; ENSG00000171819, ANGPTL7, angiopoietin like 7, [Score=108, Expect=5e-27]; ENSG00000154188, ANGPT1, angiopoietin 1, [Score=107, Expect=7e-26]; ENSG00000130812, ANGPTL6, angiopoietin like 6, [Score=105, Expect=2e-25]; ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=103, Expect=2e-24]} {Mouse: ENSMUSG00000028989, Angptl7, angiopoietin-like 7, [Score=110, Expect=5e-28]; ENSMUSG00000004105, Angptl2, angiopoietin-like 2, [Score=108, Expect=2e-26]; ENSMUSG00000022309, Angpt1, angiopoietin 1, [Score=107, Expect=7e-26]} {Dmel: FBgn0030163, CG1791, [Score=93.6, Expect=5e-23]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=89.4, Expect=5e-20]} {RNA1310_118725} |
75. | MligTC455_44120 | 125 | 2.61 | Mlig455_041513 | Neo: - Age: Up-Down-Down Region-enriched R2: 7.169/0.00020 |
0.984 | - | - | - | - | - | 0.984 | Mlig455_041513 {REF} {Length: 644} {NoTransDecoderORF} {RNA1310_39164} {RNA815_4344} | |
76. | MligTC455_54199 | 49 | 1.01 | Mlig455_034715, Mlig455_067590 | Neo: - Age: - Region-enriched R4: 5.064/0.03900 Regeneration-downregulated R4: -6.361 Regeneration-depleted R4: -6.361 |
0.984 | - | - | - | - | - | 0.984 | Mlig455_034715 {REF} {Length: 5399} {Pfam: PMP-22/EMP/MP20/Claudin family [PF00822.22, score=41.4]} {Smed: dd_Smed_v6_16515_0_1, dd_Smed_v6_16515_0_1, [Score=94.4, Expect=2e-21]} {RNA1310_64595} {RNA815_44335} Mlig455_067590 {REF} {Length: 3463} {Pfam: PMP-22/EMP/MP20/Claudin family [PF00822.22, score=27.2]} {Smed: dd_Smed_v6_20712_0_1, dd_Smed_v6_20712_0_1, [Score=74.3, Expect=5e-15]} {RNA1310_64595} {RNA815_44335} |
|
77. | MligTC455_09470 | 14 | 0.29 | Mlig455_034931 | Neo: - Age: - |
0.983 | - | - | - | - | - | 0.983 | Mlig455_034931 {REF} {Length: 484} {NoTransDecoderORF} {RNA1310_124147} | |
78. | MligTC455_31370 | 27 | 0.55 | Mlig455_035805 | Neo: - Age: - |
ASIC1 | 0.983 | - | - | - | - | - | 0.983 | Mlig455_035805 {REF} {Length: 3035} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=182.8]} {Human: ENSG00000110881, ASIC1, acid sensing ion channel subunit 1, [Score=60.1, Expect=8e-09]} {Mouse: ENSMUSG00000023017, Asic1, acid-sensing (proton-gated) ion channel 1, [Score=58.5, Expect=2e-08]} {Smed: dd_Smed_v6_16346_0_1, dd_Smed_v6_16346_0_1, [Score=107, Expect=3e-24]} {RNA1310_49983} {RNA815_25991} |
79. | MligTC455_41285 | 139 | 2.89 | Mlig455_069278 | Neo: - Age: logFC(26M/2M)=-0.469 Region-enriched R8: 4.794/0.00005 |
TRPM7 | 0.983 | - | - | - | - | - | 0.983 | Mlig455_069278 {REF} {Length: 4453} {tRNA: Val(CAC),pseudo, score=20.3} {Pfam: SLOG in TRPM [PF18139.3, score=112.9]; Ion transport protein [PF00520.33, score=47.3]; SLOG in TRPM, prokaryote [PF18171.3, score=33.2]} {Human: ENSG00000092439, TRPM7, transient receptor potential cation channel subfamily M member 7, [Score=280, Expect=3e-76]} {Mouse: ENSMUSG00000027365, Trpm7, transient receptor potential cation channel, subfamily M, member 7, [Score=281, Expect=9e-77]} {Dmel: FBgn0265194, Trpm, Transient receptor potential cation channel, subfamily M, [Score=292, Expect=1e-81]} {Celegans: WBGene00001796, gtl-2, Gon-Two Like (TRP subfamily), [Score=165, Expect=7e-41]} {Smed: dd_Smed_v6_9288_0_1, dd_Smed_v6_9288_0_1, [Score=411, Expect=1e-123]} {RNA1509_14642} {RNA1310_2379, RNA1509_14642} {RNA1509_14642, RNA815_1069} |
80. | MligTC455_43173 | 392 | 8.16 | Mlig455_037383 | Neo: - Age: Up-Down-Down Regeneration-downregulated TP: -5.031 Regeneration-depleted TP: -5.031 |
C2orf16 | 0.983 | - | - | - | - | - | 0.983 | Mlig455_037383 {REF} {Length: 2450} {Pfam: Cornifin (SPRR) family [PF02389.17, score=23.4]} {Human: ENSG00000221843, C2orf16, chromosome 2 open reading frame 16, [Score=80.1, Expect=7e-15]} {RNA1509_52401} {RNA1310_14622.1} {RNA815_17994} |
81. | MligTC455_44525 | 3358 | 69.96 | Mlig455_004678, Mlig455_004741, Mlig455_004755, Mlig455_004840 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.742 Region-enriched R2: 10.296/0.00000 |
0.983 | - | - | - | - | - | 0.983 | Mlig455_004678 {REF} {Length: 845} {RNA1509_25712} {RNA1310_68954.2} {RNA815_35323} Mlig455_004741 {REF} {Length: 961} {RNA1509_25712} {RNA1310_68954.1} {RNA815_35323} Mlig455_004755 {REF} {Length: 1059} {RNA1509_25712} {RNA1310_68954.2} {RNA815_35323} Mlig455_004840 {REF} {Length: 918} {RNA1509_25712, RNA1509_29691} {RNA1310_68954.2, RNA1509_25712, RNA1509_29691} {RNA1509_25712, RNA1509_29691, RNA815_35323} |
|
82. | MligTC455_44809 | 88 | 1.83 | Mlig455_035938 | Neo: - Age: - |
0.983 | - | - | - | - | - | 0.983 | Mlig455_035938 {REF} {Length: 1369} {Smed: dd_Smed_v6_42798_0_1, dd_Smed_v6_42798_0_1, [Score=55.8, Expect=3e-09]} {RNA1310_28961.1} {RNA815_27532} | |
83. | MligTC455_50694 | 602 | 12.54 | Mlig455_058794, Mlig455_070066 | Neo: - Age: Down-Down-Up Region-specific R2: 5.478 Region-enriched R2: 3.805/0.01454 |
0.983 | - | - | - | - | - | 0.983 | Mlig455_058794 {REF} {Length: 776} {RNA1310_76208} {RNA815_49041} Mlig455_070066 {REF} {Length: 781} {RNA1310_76208} {RNA815_49041} |
|
84. | MligTC455_02528 | 5 | 0.11 | Mlig455_059234 | Neo: - Age: - |
WBP2NL | 0.982 | - | - | - | - | - | 0.982 | Mlig455_059234 {REF} {Length: 415} {Human: ENSG00000183066, WBP2NL, WBP2 N-terminal like, [Score=48.5, Expect=5e-07]} {Mouse: ENSMUSG00000022455, Wbp2nl, WBP2 N-terminal like, [Score=44.3, Expect=1e-05]} |
85. | MligTC455_03458 | 3 | 0.06 | Mlig455_035221 | Neo: - Age: - |
0.982 | - | - | - | - | - | 0.982 | Mlig455_035221 {REF} {Length: 1321} {NoTransDecoderORF} | |
86. | MligTC455_03548 | 13 | 0.28 | Mlig455_057012 | Neo: - Age: - |
0.982 | - | - | - | - | - | 0.982 | Mlig455_057012 {REF} {Length: 166} {NoTransDecoderORF} {RNA1310_132416} | |
87. | MligTC455_08596 | 9 | 0.19 | Mlig455_062597 | Neo: - Age: - |
0.982 | - | - | - | - | - | 0.982 | Mlig455_062597 {REF} {Length: 2237} {NoTransDecoderORF} {RNA1509_38974, RNA1509_56801} {RNA1310_38331, RNA1509_38974, RNA1509_56801} {RNA1509_38974, RNA1509_56801, RNA815_48510} | |
88. | MligTC455_09237 | 6 | 0.12 | Mlig455_040950 | Neo: - Age: - |
0.982 | - | - | - | - | - | 0.982 | Mlig455_040950 {REF} {Length: 774} | |
89. | MligTC455_13635 | 16 | 0.33 | Mlig455_014568 | Neo: - Age: - |
0.982 | - | - | - | - | - | 0.982 | Mlig455_014568 {REF} {Length: 1825} | |
90. | MligTC455_15027 | 18 | 0.37 | Mlig455_044364 | Neo: - Age: - |
0.982 | - | - | - | - | - | 0.982 | Mlig455_044364 {REF} {Length: 1060} {NoTransDecoderORF} {RNA1310_105534.1} | |
91. | MligTC455_15536 | 41 | 0.86 | Mlig455_030649 | Neo: - Age: - |
0.982 | - | - | - | - | - | 0.982 | Mlig455_030649 {REF} {Length: 1146} {RNA1310_33769.1} {RNA815_16068} | |
92. | MligTC455_19279 | 4576 | 95.33 | Mlig455_057411 | Neo: - Age: Down-Down-Up, logFC(26M/2M)=-0.654 Region-specific R2: 5.173 Region-enriched R2: 4.585/0.00000 |
CHRNA10 | 0.982 | - | - | - | - | - | 0.982 | Mlig455_057411 {REF} {Length: 1075} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=85.3]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=91.3, Expect=1e-20]} {Mouse: ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=92.0, Expect=7e-21]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=88.2, Expect=1e-19]} {Dmel: FBgn0086778, nAChRalpha7, nicotinic Acetylcholine Receptor alpha7, [Score=110, Expect=2e-27]} {Celegans: WBGene00000058, acr-19, AcetylCholine Receptor; Acetylcholine receptor (63.2 kD) (Acr-19), [Score=120, Expect=4e-31]} {Smed: dd_Smed_v6_18184_0_1, dd_Smed_v6_18184_0_1, [Score=96.3, Expect=8e-23]} {RNA1509_1306} {RNA1310_34970} {RNA815_15305.1} |
93. | MligTC455_23278 | 386 | 8.04 | Mlig455_037778 | Neo: - Age: logFC(26M/2M)=-0.605 |
SLC13A3 | 0.982 | - | - | - | - | - | 0.982 | Mlig455_037778 {REF} {Length: 3476} {Pfam: Sodium:sulfate symporter transmembrane region [PF00939.21, score=294.2]; Citrate transporter [PF03600.18, score=99.7]} {Human: ENSG00000158296, SLC13A3, solute carrier family 13 member 3, [Score=377, Expect=4e-121]} {Mouse: ENSMUSG00000018459, Slc13a3, solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 3, [Score=367, Expect=1e-117]; ENSMUSG00000001095, Slc13a2, solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 2, [Score=359, Expect=9e-115]} {Dmel: FBgn0036816, Indy, I'm not dead yet, [Score=175, Expect=1e-46]} {Celegans: WBGene00007138, B0285.6, Uncharacterized transporter B0285.6, [Score=194, Expect=2e-53]} {Smed: dd_Smed_v6_5476_0_1, dd_Smed_v6_5476_0_1, [Score=315, Expect=3e-98]} {RNA1509_1723, RNA1509_48306} {RNA1310_5497, RNA1509_48306} {RNA1509_48306, RNA815_1709} |
94. | MligTC455_23958 | 9 | 0.18 | Mlig455_015079, Mlig455_015192, Mlig455_027152 | Neo: - Age: - |
0.982 | - | - | - | - | - | 0.982 | Mlig455_015079 {REF} {Length: 1064} {Pfam: Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=57.5]} {RNA1310_34740} {RNA815_15663} Mlig455_015192 {REF} {Length: 1331} {Pfam: Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=62.7]} {RNA1310_34740} {RNA815_15663} Mlig455_027152 {REF} {Length: 1335} {Pfam: Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=61.4]} {RNA1310_34740} {RNA815_15663} |
|
95. | MligTC455_33832 | 112 | 2.34 | Mlig455_029411 | Neo: - Age: Up-Down-Down Region-enriched R2: 5.300/0.00016 |
GLRA3 | 0.982 | - | - | - | - | - | 0.982 | Mlig455_029411 {REF} {Length: 3686} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=149.0]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=84.5]} {Human: ENSG00000145451, GLRA3, glycine receptor alpha 3, [Score=257, Expect=5e-80]; ENSG00000145888, GLRA1, glycine receptor alpha 1, [Score=253, Expect=3e-78]; ENSG00000101958, GLRA2, glycine receptor alpha 2, [Score=250, Expect=4e-77]} {Mouse: ENSMUSG00000038257, Glra3, glycine receptor, alpha 3 subunit, [Score=251, Expect=2e-77]; ENSMUSG00000018589, Glra2, glycine receptor, alpha 2 subunit, [Score=249, Expect=5e-77]; ENSMUSG00000000263, Glra1, glycine receptor, alpha 1 subunit, [Score=248, Expect=2e-76]; ENSMUSG00000018595, Glra4, glycine receptor, alpha 4 subunit, [Score=243, Expect=1e-74]} {Dmel: FBgn0024963, GluClalpha, [Score=253, Expect=2e-78]} {Celegans: WBGene00000233, avr-15, GluClalpha2B protein, [Score=259, Expect=7e-81]} {Smed: dd_Smed_v6_11342_0_1, dd_Smed_v6_11342_0_1, [RH, Score=480, Expect=1e-167]} {RNA1509_35986} {RNA1310_35528} {RNA815_35433} |
96. | MligTC455_35500 | 5 | 0.1 | Mlig455_041081 | Neo: - Age: - |
HACE1 | 0.982 | - | - | - | - | - | 0.982 | Mlig455_041081 {REF} {Length: 1129} {Pfam: Ankyrin repeat [PF00023.32, score=76.5]; Ankyrin repeats (3 copies) [PF12796.9, score=72.7]; Ankyrin repeats (many copies) [PF13637.8, score=68.8]; Ankyrin repeats (many copies) [PF13857.8, score=59.6]; Ankyrin repeat [PF13606.8, score=43.3]} {Human: ENSG00000085382, HACE1, HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1, [Score=77.4, Expect=4e-15]} {Mouse: ENSMUSG00000038822, Hace1, HECT domain and ankyrin repeat containing, E3 ubiquitin protein ligase 1, [Score=77.0, Expect=4e-15]; ENSMUSG00000015468, Notch4, notch 4, [Score=73.6, Expect=6e-14]} {Dmel: FBgn0043884, mask, multiple ankyrin repeats single KH domain, [Score=61.2, Expect=5e-10]} {Celegans: WBGene00006780, unc-44, AO66 ankyrin, [Score=60.8, Expect=6e-10]} {Smed: dd_Smed_v6_10835_0_1, dd_Smed_v6_10835_0_1, [Score=65.5, Expect=1e-11]} {RNA1509_43154} {RNA1310_25352} {RNA815_10888} |
97. | MligTC455_35895 | 102 | 2.12 | Mlig455_063971 | Neo: - Age: - |
RYK | 0.982 | - | - | - | - | - | 0.982 | Mlig455_063971 {REF} {Length: 3496} {Pfam: Protein tyrosine and serine/threonine kinase [PF07714.19, score=209.4]; WIF domain [PF02019.20, score=109.7]; Protein kinase domain [PF00069.27, score=79.1]} {Human: ENSG00000163785, RYK, receptor-like tyrosine kinase, [Score=202, Expect=1e-55]} {Mouse: ENSMUSG00000032547, Ryk, receptor-like tyrosine kinase, [RH, Score=202, Expect=2e-55]} {Dmel: FBgn0015380, drl, derailed, [RH, Score=239, Expect=4e-69]} {Celegans: WBGene00003007, lin-18, Inactive tyrosine-protein kinase RYK, [Score=179, Expect=6e-48]} {Smed: dd_Smed_v6_12594_0_2, dd_Smed_v6_12594_0_2, [Score=201, Expect=3e-55]} {RNA1509_58811} {RNA1310_6671.2} {RNA815_41921} |
98. | MligTC455_43961 | 30 | 0.62 | Mlig455_027626 | Neo: - Age: - |
0.982 | - | - | - | - | - | 0.982 | Mlig455_027626 {REF} {Length: 602} {Pfam: PAN domain [PF00024.28, score=26.5]; PAN domain [PF14295.8, score=21.8]} {RNA1310_35396.1} {RNA815_23500} | |
99. | MligTC455_52746 | 33 | 0.7 | Mlig455_036774 | Neo: - Age: - |
0.982 | - | - | - | - | - | 0.982 | Mlig455_036774 {REF} {Length: 1992} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=90.0]} {Smed: dd_Smed_v6_16274_0_1, dd_Smed_v6_16274_0_1, [Score=77.4, Expect=7e-15]} {RNA1310_26715} {RNA815_32348} | |
100. | MligTC455_53333 | 44 | 0.91 | Mlig455_019019, Mlig455_055684 | Neo: - Age: Up-Down-Up Region-enriched R4: 4.725/0.03950 |
CHRNA7 | 0.982 | - | - | - | - | - | 0.982 | Mlig455_019019 {REF} {Length: 2615} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=154.0]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=93.9]} {Human: ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=210, Expect=2e-59]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=208, Expect=5e-59]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=207, Expect=8e-59]; ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=206, Expect=3e-58]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=209, Expect=1e-59]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=205, Expect=3e-58]} {Dmel: FBgn0000039, nAChRalpha2, nicotinic Acetylcholine Receptor alpha2, [Score=221, Expect=3e-63]} {Celegans: WBGene00006774, unc-38, Acetylcholine receptor subunit alpha-type unc-38, [Score=190, Expect=7e-53]} {Smed: dd_Smed_v6_9503_0_1, dd_Smed_v6_9503_0_1, [Score=426, Expect=5e-142]} {RNA1509_56207} {RNA1310_26355} {RNA815_26644} Mlig455_055684 {REF} {Length: 2604} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=154.0]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=94.7]} {Human: ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=211, Expect=9e-60]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=209, Expect=3e-59]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=208, Expect=5e-59]; ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=207, Expect=7e-59]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=209, Expect=9e-60]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=204, Expect=1e-57]} {Dmel: FBgn0000039, nAChRalpha2, nicotinic Acetylcholine Receptor alpha2, [Score=222, Expect=1e-63]} {Celegans: WBGene00006774, unc-38, Acetylcholine receptor subunit alpha-type unc-38, [Score=190, Expect=6e-53]} {Smed: dd_Smed_v6_9503_0_1, dd_Smed_v6_9503_0_1, [Score=427, Expect=3e-142]} {RNA1509_56207} {RNA1310_26355} {RNA815_26644} |